World's Best Scientists 2026 revealed!
Ignaty Leshchiner

Ignaty Leshchiner

D-Index & Metrics

Molecular Biology

D-Index
48
Citations
24562
World Ranking
2653
National Ranking
1292

Ignaty Leshchiner publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Ignaty Leshchiner sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 143 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Ignaty Leshchiner D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Ignaty Leshchiner sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 48 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Ignaty Leshchiner is affiliated with the Broad Institute in the United States and focuses on research primarily in the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their work spans multiple subfields, including Cancer Research, Molecular Biology, Genetics, Pulmonary and Respiratory Medicine, and Oncology.

The main research topics covered by Leshchiner include:

  • Cancer Genomics and Diagnostics
  • Chronic Lymphocytic Leukemia Research
  • Genetic factors in colorectal cancer
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Pancreatic and Hepatic Oncology Research
  • Advanced Breast Cancer Therapies

Leshchiner has published research in numerous venues, with frequent contributions to:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Nature Communications
  • Journal of Clinical Oncology

Some of the notable recent papers include:

  • The evolutionary history of 2,658 cancers, 2020, Nature
  • Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes, 2021, Cell
  • Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer, 2021, Cancer Discovery
  • Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression, 2020, Journal of Clinical Oncology
  • Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer, 2023, Nature Genetics

Frequent collaborators in their research include:

  • Gad Getz
  • Dimitri Livitz
  • Brian P. Danysh
  • Chip Stewart
  • Laxmi Parida

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

  • Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

    Benjamin J. Raphael;Ralph H. Hruban;Andrew J. Aguirre;Richard A. Moffitt

  • Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

    Bjoern Chapuy;Chip Stewart;Andrew J Dunford;Jaegil Kim

  • Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer

    Justin F. Gainor;Leila Dardaei;Satoshi Yoda;Luc Friboulet

  • The evolutionary history of 2,658 cancers

    Moritz Gerstung;Moritz Gerstung;Clemency Jolly;Ignaty Leshchiner;Stefan C Dentro;Stefan C Dentro;Stefan C Dentro

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors

    Viktor A. Adalsteinsson;Viktor A. Adalsteinsson;Gavin Ha;Gavin Ha;Samuel S. Freeman;Samuel S. Freeman;Atish D. Choudhury

  • Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma

    Lauren Fishbein;Lauren Fishbein;Ignaty Leshchiner;Ignaty Leshchiner;Vonn Walter;Vonn Walter;Ludmila Danilova;Ludmila Danilova

  • The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution

    Orit Rozenblatt-Rosen;Aviv Regev;Aviv Regev;Aviv Regev;Philipp Oberdoerffer;Tal Nawy

  • Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

    Stefan C. Dentro;Stefan C. Dentro;Stefan C. Dentro;Ignaty Leshchiner;Kerstin Haase;Maxime Tarabichi;Maxime Tarabichi

  • Resensitization to Crizotinib by the Lorlatinib Alk Resistance Mutation L1198F.

    Shaw At;Friboulet L;Leshchiner I;Gainor Jf

  • A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer

    Paz Polak;Jaegil Kim;Lior Z Braunstein;Lior Z Braunstein;Rosa Karlic

  • Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.

    Lipika Goyal;Supriya K. Saha;Leah Y. Liu;Giulia Siravegna

  • An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge.

    Catherine A. Brownstein;Alan H. Beggs;Nils Homer;Barry Merriman

  • Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.

    Aparna R Parikh;Ignaty Leshchiner;Liudmila Elagina;Lipika Goyal

  • Integrated Molecular Characterization of Uterine Carcinosarcoma

    Andrew D. Cherniack;Hui Shen;Vonn Walter;Chip Stewart

  • Paired exome analysis of Barrett's esophagus and adenocarcinoma.

    Matthew D Stachler;Matthew D Stachler;Amaro Taylor-Weiner;Shouyong Peng;Aaron McKenna

  • Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer

    J. Gainor;L. Dardaei;S. Yoda;L. Friboulet

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

Frequent Co-Authors

Gad Getz
Gad Getz Broad Institute
Rameen Beroukhim
Rameen Beroukhim Harvard University
Catherine J. Wu
Catherine J. Wu Harvard University
Chip Stewart
Chip Stewart Broad Institute
Jennifer R. Brown
Jennifer R. Brown Harvard University
Todd R. Golub
Todd R. Golub Harvard University
Michael S. Lawrence
Michael S. Lawrence Harvard University
Matthew Meyerson
Matthew Meyerson Harvard University
Donna Neuberg
Donna Neuberg Harvard University
Paul C. Boutros
Paul C. Boutros University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students pursuing Molecular Biology may find compelling career options beyond traditional laboratory roles. Several online pathways align with the scientific and analytical skills gained in this field. Those interested in blending molecular biology with mental health care might explore an online master's in counseling, which offers a versatile entry into counseling careers. Similarly, a background in biology can be an asset for those considering a clinical psychology degree online, especially for roles integrating neuroscience or behavioral research.

For students seeking a quicker route to the workforce, completing a human services bachelors degree online can lead to roles in case management, community outreach, or advocacy. Additionally, educators or science graduates exploring new directions may find inspiration in transitioning from teacher to speech-language therapist. Read more about the journey on teacher to speech and language therapist.

These online degrees not only expand career opportunities but also offer flexible, affordable routes to enter high-demand fields related to science, healthcare, and public service.

Best Scientists Citing Ignaty Leshchiner

Trending Scientists

Recently Published Articles